THREE weeks after submitting its application, the Food and Drug Administration (FDA) has finally given the British pharma company AstraZeneca an emergency use authorization (EUA) for its COVID-19 vaccine.
“After a thorough review of the currently available data by our medical and regulatory experts, the FDA is granting an emergency use authorization to the COVID-19 vaccine AstraZeneca,” FDA Director General Eric Domingo said during a Laging Handa briefing.
AstraZeneca’s vaccine is the second to have been given an EUA by the government following the Pfizer-BioNTech vaccine.
